risankizumab,ustekinumab
abbvie,janssen
[]
 it's also still such depressingly low rates of remission. as a patient having to decide at the moment between surgery or trying yet more drugs, graphs like these don't fill me with hope; they make me want to have surgery.
Keen painter and woodcarver; can juggle